Furthermore, variability in the onset of AD, as well as other tauopathies, suggests that environmental and genetic factors117, 118 and the role of chaperone systems and their decline in maintaining proteostasis within aged-tissue or AD-tissue may all be significant factors in generating pathogenic tau species and increasing susceptibility to AD.119. The gene discussed is MAPT; the disease is Alzheimer disease.